Abstract
The major factors contributing to the recommencement of clinical heart transplantation in the United Kingdom last year were the steadily improving results from Stanford University, the clarification of the diagnosis of brain death, and advances in preserving donor hearts. Twelve men aged 16 to 52 years received heart transplants at Papworth Hospital from January 1979 to July 1980. Six had cardiomyopathies and six ischaemic heart disease. The donors were aged 16 to 35 (mean 21) years. A combination of road and air transport was used to transport the heart to Papworth in seven cases. The total donor heart ischaemic time ranged from 108 to 171 minutes (mean 151), and early graft function was satisfactory in all cases. Postoperative management was directed towards preventing rejection and infection. Equine antihuman thymocyte globulin, prednisolone, and azathioprine were used for immunosuppression. Endomyocardial biopsy was performed every 10 to 14 days during the early postoperative period. There were three deaths: one at 17 days from brain damage and two at 59 and 76 days from rejection. Of the remaining nine patients six left hospital and three returned to work. The number of patients who might benefit from heart transplantation is large, but the cost is high. The cost would fall if an effective non-toxic immunosuppressive agent were developed. Meanwhile, a careful evaluation of the benefits of heart transplantation should continue.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnard C. N. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J. 1967 Dec 30;41(48):1271–1274. [PubMed] [Google Scholar]
- Baumgartner W. A., Reitz B. A., Bieber C. P., Oyer P. E., Shumway N. E., Stinson E. B. Current expectations in cardiac transplantation. J Thorac Cardiovasc Surg. 1978 Apr;75(4):525–530. [PubMed] [Google Scholar]
- Griepp R. B., Stinson E. B., Bieber C. P., Oyer P. E., Reitz B. A., Copeland J. G., Shumway N. E. Heart and other organs. Increasing patient survival following heart transplantation. Transplant Proc. 1977 Mar;9(1):197–201. [PubMed] [Google Scholar]
- Griepp R. B., Stinson E. B., Bieber C. P., Reitz B. A., Copeland J. G., Oyer P. E., Shumway N. E. Control of graft arteriosclerosis in human heart transplant recipients. Surgery. 1977 Mar;81(3):262–269. [PubMed] [Google Scholar]
- Griepp R. B., Stinson E. B., Clark D. A., Dong E., Jr, Shumway N. E. The cardiac donor. Surg Gynecol Obstet. 1971 Nov;133(5):792–798. [PubMed] [Google Scholar]
- Jamieson S. W., Reitz B. A., Oyer P. E., Bieber C. P., Stinson E. B., Shumway N. E. Current management of cardiac transplant recipients. Br Heart J. 1979 Dec;42(6):703–708. doi: 10.1136/hrt.42.6.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krikorian J. G., Anderson J. L., Bieber C. P., Penn I., Stinson E. B. Malignant neoplasms following cardiac transplantation. JAMA. 1978 Aug 18;240(7):639–643. [PubMed] [Google Scholar]
- LOWER R. R., SHUMWAY N. E. Studies on orthotopic homotransplantation of the canine heart. Surg Forum. 1960;11:18–19. [PubMed] [Google Scholar]
- LOWER R. R., STOFER R. C., HURLEY E. J., DONG E., Jr, COHN R. B., SHUMWAY N. E. Successful homotransplantation of the canine heart after anoxic preservation for seven hours. Am J Surg. 1962 Aug;104:302–306. doi: 10.1016/0002-9610(62)90332-x. [DOI] [PubMed] [Google Scholar]
- LOWER R. R., STOFER R. C., SHUMWAY N. E. Homovital transplantation of the heart. J Thorac Cardiovasc Surg. 1961 Feb;41:196–204. [PubMed] [Google Scholar]
- Lower R. R., Dong E., Jr, Glazener F. S. Electrocardiograms of dogs with heart homografts. Circulation. 1966 Mar;33(3):455–460. doi: 10.1161/01.cir.33.3.455. [DOI] [PubMed] [Google Scholar]
- Remington J. S., Gaines J. D., Griepp R. B., Shumway N. E. Further experience with infection after cardiac transplantation. Transplant Proc. 1972 Dec;4(4):699–705. [PubMed] [Google Scholar]